Cargando…
Testing of drugs using human feto-maternal interface organ-on-chips provide insights into pharmacokinetics and efficacy
Objectives: To improve preclinical drug testing during pregnancy, we developed multiple microfluidic organ-on-chip (OOC) devices that represent the structure, functions, and responses of the two feto-maternal interfaces (FMis) in humans (fetal membrane [FMi-OOC] and placenta [PLA-OOC]). This study u...
Autores principales: | Richardson, Lauren S., K. Kammala, Ananth, Costantine, Maged M., Fortunato, Stephen J., Radnaa, Enkhtuya, Kim, Sungjin, Taylor, Robert N., Han, Arum, Menon, Ramkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682442/ https://www.ncbi.nlm.nih.gov/pubmed/36322152 http://dx.doi.org/10.1039/d2lc00691j |
Ejemplares similares
-
Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery
por: Tantengco, Ourlad Alzeus G., et al.
Publicado: (2022) -
Organ-On-Chip Technology: The Future of Feto-Maternal Interface Research?
por: Richardson, Lauren, et al.
Publicado: (2020) -
Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy
por: Kammala, Ananth K., et al.
Publicado: (2023) -
Fetal Membranes Contribute to Drug Transport across the Feto-Maternal Interface Utilizing the Breast Cancer Resistance Protein (BCRP)
por: Kammala, Ananthkumar, et al.
Publicado: (2022) -
Fetal membrane at the feto-maternal interface: An underappreciated and understudied intrauterine tissue
por: Richardson, Lauren, et al.
Publicado: (2022)